The Statin Therapy for Patients with Diabetes (SPD) measure is a key performance metric used by NCQA to assess the quality of care provided to individuals with diabetes.
Measure Criteria: The SPD measure is the percentage of US Family Health Plan beneficiaries aged 40-75 with diabetes who do not have clinical Atherosclerotic Cardiovascular Disease (ASCVD) who have at least one fill of a statin medication during the measurement year.
Our goal is to ensure eligible patients with diabetes are prescribed a statin unless they meet certain exclusion criteria.
Documentation of exclusions each year is important to maintain accurate information and properly exclude patients from this measure calculation.
EXCLUSIONS
Patients are excluded if, at any point during the measurement year, any of the following apply.
They:Patients are excluded if, at any point during the measurement year OR the year prior to the measurement year, any of the following apply.
They:Patients are excluded if, at any point during the year prior to the measurement year, they:
Patients are excluded if, at ANY time during the member’s history through the measurement year, they have had the following:
Hospice or Palliative Care
Z51.5
End-Stage Renal Disease (ESRD)
N18.6, Z99.2, N19
Rhabdomyolysis or Myopathy
M62.82, G72.9, G72.89
Pregnancy
O09.90, Z33.1
Cirrhosis
K70.30, K71.7, P78.81
ICD-10 code list is illustrative and not comprehensive.